• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home The Classics Imaging Classics

CT utilization associated with future cancer risk [Classics Series]

by2 Minute Medicine
January 1, 2025
in General Chronic Disease Classics, Hematology/Oncology Classics, Imaging Classics, The Classics
Reading Time: 4 mins read
ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]
Share on FacebookShare on Twitter

1. Risk projection models estimated 29,000 potential excess cancers related to computed tomography (CT ) scans performed in the United States in 2007.

2. Efforts to reduce overall radiation dose from CT, including reduction of unnecessary scans and reducing dose per procedure, continue to be a high priority.

Original Date of Publication: December 2009

This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Radiology, 1e (The Classics Series).

Study Rundown: CT has revolutionized medical practice through its speed, availability, and high resolution of anatomical structures free of superimposition. Given its advantages and relative safety over exploratory surgery, its use as a preventative and diagnostic tool for cancer has increased dramatically in the United States since its introduction in the 1970s. However, the nature of CT exposes patients to larger radiation doses than conventional x-ray imaging. As a result, the average radiation dose per United States resident per year has correspondingly increased. The benefits of CT are clear and the radiobiological harm of a single scan are likely insignificant. However, a 2009 retrospective cross-sectional study by Smith-Bindman et al. found that radiation doses from CT scans are higher and more variable than reported. The risk of cumulative CT scans in the patient population may be overlooked and be a cause for public health concern.

While evaluation of the increased risk for cancer from CT is controversial, studies have revived concerns about the risk it poses for developing cancer. In the present cross-sectional study conducted by de González et al., risk models based on cancer rates among survivors of the atomic bomb blasts of World War II (WWII) were used to project the number of future cancers that could be related to radiation from CT scans; these were modeled risks, rather than observed cancer cases. Using both CT scan frequency and organ-specific doses, the study further indicated that cancers associated with the most frequently used CT scans (abdomen and pelvis) and highest-dose scans (chest CT angiography) had large contributions to projected cancer risk. Though potentially misleading due to the data set used, the results indicate a substantial possible increased risk of cancer.

RELATED REPORTS

Probiotic supplementation is associated with reduced risk of death and necrotizing enterocolitis among preterm infants

Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

Please click to read study in Archives of Internal Medicine

In-Depth [cross-sectional]: This epidemiologic study primarily used Medicare claims data, the IMV Medical Information survey of CT scan use in 2007, and a national commercial insurance database (NCID) to estimate the age and gender distribution for CT scan frequency in the United States. Linear extrapolation was used to exclude the estimated scans on those who did not survive 5 years and those with an associated diagnosis code of cancer. Organ-specific doses were based on the Food and Drug Administration’s National Evaluation of X -Ray Trends survey and cross checked with an available literature review. Pediatric scans were assumed to follow the recommended lower radiation protocols. Risk models (excluding breast and thyroid) were based on cancer rates among the long -term survivors of the Japanese atomic bomb of WWII. Risk calculations were run using Monte Carlo simulation methods. A linear no-threshold dose-response model was used.

After excluding scans on patients not surviving greater than 5 years and patients with a cancer diagnosis (gross total of 72 million), an estimated 57 million CT scans were used in the calculation for future cancer risk. Overall, an estimated 29,000 (95%UL 15 000 – 45 000) future cancers were linked to CT scans in the United States in 2007. Abdomen and pelvis (n=14 000, 95%UL 6900 – 25 000), chest (n=4100, 95%UL 1900-8100), and head (n=4000, 95%UL 1100-8700) were found to be scan types performed most frequently. Chest CT angiography (n=2700, 95%UL 1300-5000) was found to be the highest-dose scan. Women were found to have increased radiation exposure due to higher frequency of use (60%) and higher incidence of breast and lung cancer, which require higher-dose scans. The risk models showed lung cancer as the most common radiation associated cancer (n=6200, 95%UL 2300-13 000), primarily due to the high frequency of exposure from chest CT . This was followed by colon cancer (n=3500, 95%UL 1000-6800) due to the high frequency of abdominal CT, and leukemia (n=2800, 95%UL 800-4800) due to high organ sensitivity. Multiple measures to reduce overall population dose, including more widespread use of American College of Radiology (ACR) appropriateness criteria, dose reduction software in CT, Image Gently and Image Wisely, and the development of dose registries have all been instituted.

de González AB, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C . Projected cancer risks from computed tomographic scans performed in the United States in 2007. Archives of Internal Medicine. 2009 Dec;169(22):2071-2077. Additional Review: Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Archives of internal medicine. 2009 Dec 14;169(22):2078 – 2086.

© 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: #cancercancercancer riskctrisk
Previous Post

The INVEST trial: Limited added utility of vertebroplasty versus sham surgery [Classics Series]

Next Post

BI-RADS study identifies mammography features with high positive predictive values for carcinoma [Classics Series]

RelatedReports

Emergency

Probiotic supplementation is associated with reduced risk of death and necrotizing enterocolitis among preterm infants

October 2, 2026
Cardiology

Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors

September 30, 2026
A collection of symbolic items such as a microscope
Artificial Intelligence

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

September 30, 2026
Artificial Intelligence

An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis

September 25, 2026
Next Post
PFO closure equivalent to medical management in prevention of recurrent stroke [PC and RESPECT trials]

Artificial intelligence-augmented decision-making failed to show non-inferiority compared to clinician judgment alone for coronary angiography patient selection

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

2 Minute Medicine Rewind January 6, 2025

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Probiotic supplementation is associated with reduced risk of death and necrotizing enterocolitis among preterm infants
  • Artificial intelligence (AI)-triggered rapid response notifications were associated with lower mortality among inpatients
  • Post-traumatic stress disorder is associated with increased risk of mild cognitive impairment and dementia among United States Veterans
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.